{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:05:52Z","timestamp":1785510352269,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"DOI":"10.7759\/cureus.90170","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T17:16:38Z","timestamp":1755278198000},"source":"Crossref","is-referenced-by-count":5,"title":["Management of Antidepressant-Induced Sexual Dysfunction: A Literature Review"],"prefix":"10.7759","author":[{"given":"Faith D","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory H","family":"Bichai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Kravetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zina","family":"Meriden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors","volume":"281","author":"Laumann EO","year":"1999","unstructured":"Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999, 281:537-544. 10.1001\/jama.281.6.537","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31819c76e9","article-title":"Sexual dysfunction, depression, and the impact of antidepressants","volume":"29","author":"Kennedy SH","year":"2009","unstructured":"Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009, 29:157-164. 10.1097\/JCP.0b013e31819c76e9","journal-title":"J Clin Psychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.110650","article-title":"Antidepressant drugs and sexual dysfunction","volume":"202","author":"Baldwin DS","year":"2013","unstructured":"Baldwin DS, Foong T. Antidepressant drugs and sexual dysfunction. Br J Psychiatry. 2013, 202:396-397. 10.1192\/bjp.bp.112.110650","journal-title":"Br J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199807006-00001","article-title":"Sexual problems in healthy and depressed persons","volume":"13","author":"Angst J","year":"1998","unstructured":"Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998, 13:S1-S4. 10.1097\/00004850-199807006-00001","journal-title":"Int Clin Psychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2017.1326650","article-title":"A comparison of sexual side effects of antidepressants with and without naltrexone","volume":"13","author":"Thapa M","year":"2017","unstructured":"Thapa M, Petrakis I, Ralevski E. A comparison of sexual side effects of antidepressants with and without naltrexone. J Dual Diagn. 2017, 13:230-235. 10.1080\/15504263.2017.1326650","journal-title":"J Dual Diagn"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A195","article-title":"Antidepressant-induced sexual dysfunction","volume":"36","author":"Gregorian RS","year":"2002","unstructured":"Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother. 2002, 36:1577-1589. 10.1345\/aph.1A195","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63247-0.00027-4","article-title":"Psychiatric disorders and sexual dysfunction","volume":"130","author":"Waldinger MD","year":"2015","unstructured":"Waldinger MD. Psychiatric disorders and sexual dysfunction. Handb Clin Neurol. 2015, 130:469-489. 10.1016\/B978-0-444-63247-0.00027-4","journal-title":"Handb Clin Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S185757","article-title":"Selective serotonin reuptake inhibitor-induced sexual dysfunction: current management perspectives","volume":"16","author":"Atmaca M","year":"2020","unstructured":"Atmaca M. Selective serotonin reuptake inhibitor-induced sexual dysfunction: current management perspectives. Neuropsychiatr Dis Treat. 2020, 16:1043-1050. 10.2147\/NDT.S185757","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ph3123614","article-title":"Pharmacogenetics of SSRIs and sexual dysfunction","volume":"3","author":"Osis L","year":"2010","unstructured":"Osis L, Bishop JR. Pharmacogenetics of SSRIs and sexual dysfunction. Pharmaceuticals (Basel). 2010, 3:3614-3628. 10.3390\/ph3123614","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2016.07.191","article-title":"Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: a narrative literature review","volume":"6","author":"Jing E","year":"2016","unstructured":"Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: a narrative literature review. Ment Health Clin. 2016, 6:191-196. 10.9740\/mhc.2016.07.191","journal-title":"Ment Health Clin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.11.1012","article-title":"The neurobiology of sexual function","volume":"57","author":"Meston CM","year":"2000","unstructured":"Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry. 2000, 57:1012-1030. 10.1001\/archpsyc.57.11.1012","journal-title":"Arch Gen Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.3.199","article-title":"Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review","volume":"182","author":"Wieck A","year":"2003","unstructured":"Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry. 2003, 182:199-204. 10.1192\/bjp.182.3.199","journal-title":"Br J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad PM","year":"2004","unstructured":"Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs. 2004, 64:2291-2314. 10.2165\/00003495-200464200-00003","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2165\/11533140-000000000-00000","article-title":"Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management","volume":"24","author":"Coker F","year":"2010","unstructured":"Coker F, Taylor D. Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management. CNS Drugs. 2010, 24:563-574. 10.2165\/11533140-000000000-00000","journal-title":"CNS Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v61n0506","article-title":"Mirtazapine substitution in SSRI-induced sexual dysfunction","volume":"61","author":"Gelenberg AJ","year":"2000","unstructured":"Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry. 2000, 61:356-360. 10.4088\/jcp.v61n0506","journal-title":"J Clin Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila SA","year":"2001","unstructured":"Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001, 7:249-264. 10.1111\/j.1527-3458.2001.tb00198.x","journal-title":"CNS Drug Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S7634","article-title":"Antidepressant-associated sexual dysfunction: impact, effects, and treatment","volume":"2","author":"Higgins A","year":"2010","unstructured":"Higgins A, Nash M, Lynch AM. Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc Patient Saf. 2010, 2:141-150. 10.2147\/DHPS.S7634","journal-title":"Drug Healthc Patient Saf"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977x(96)00016-8","article-title":"The effects of moclobemide on sexual desire and function in healthy volunteers","volume":"6","author":"Kennedy SH","year":"1996","unstructured":"Kennedy SH, Ralevski E, Davis C, Neitzert C. The effects of moclobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol. 1996, 6:177-181. 10.1016\/0924-977x(96)00016-8","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v61n0406","article-title":"Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine","volume":"61","author":"Kennedy SH","year":"2000","unstructured":"Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 2000, 61:276-281. 10.4088\/jcp.v61n0406","journal-title":"J Clin Psychiatry"},{"key":"ref20","article-title":"Antidepressant-induced sexual dysfunction","volume":"59","author":"Segraves RT","year":"1998","unstructured":"Segraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry. 1998, 59:48-54.","journal-title":"J Clin Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v62n0106","article-title":"Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline","volume":"62","author":"Ferguson JM","year":"2001","unstructured":"Ferguson JM, Shrivastava RK, Stahl SM, et al.. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry. 2001, 62:24-29. 10.4088\/jcp.v62n0106","journal-title":"J Clin Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v63n0414","article-title":"Prevalence of sexual dysfunction among newer antidepressants","volume":"63","author":"Clayton AH","year":"2002","unstructured":"Clayton AH, Pradko JF, Croft HA, et al.. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002, 63:357-366. 10.4088\/jcp.v63n0414","journal-title":"J Clin Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2008.00067.x","article-title":"Vilazodone: a 5-HT1A receptor agonist\/serotonin transporter inhibitor for the treatment of affective disorders","volume":"15","author":"Dawson LA","year":"2009","unstructured":"Dawson LA, Watson JM. Vilazodone: a 5-HT1A receptor agonist\/serotonin transporter inhibitor for the treatment of affective disorders. CNS Neurosci Ther. 2009, 15:107-117. 10.1111\/j.1755-5949.2008.00067.x","journal-title":"CNS Neurosci Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000145","article-title":"Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study","volume":"32","author":"Clayton AH","year":"2017","unstructured":"Clayton AH, Durgam S, Li D, et al.. Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study. Int Clin Psychopharmacol. 2017, 32:27-35. 10.1097\/YIC.0000000000000145","journal-title":"Int Clin Psychopharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12004","article-title":"The effect of vilazodone on sexual function during the treatment of major depressive disorder","volume":"10","author":"Clayton AH","year":"2013","unstructured":"Clayton AH, Kennedy SH, Edwards JB, Gallipoli S, Reed CR. The effect of vilazodone on sexual function during the treatment of major depressive disorder. J Sex Med. 2013, 10:2465-2476. 10.1111\/jsm.12004","journal-title":"J Sex Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez C","year":"2015","unstructured":"Sanchez C, Asin KE, Artigas F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol Ther. 2015, 145:43-57. 10.1016\/j.pharmthera.2014.07.001","journal-title":"Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2019.06.018","article-title":"Paroxetine, but not vortioxetine, impairs sexual functioning compared with placebo in healthy adults: a randomized, controlled trial","volume":"16","author":"Jacobsen P","year":"2019","unstructured":"Jacobsen P, Zhong W, Nomikos G, Clayton A. Paroxetine, but not vortioxetine, impairs sexual functioning compared with placebo in healthy adults: a randomized, controlled trial. J Sex Med. 2019, 16:1638-1649. 10.1016\/j.jsxm.2019.06.018","journal-title":"J Sex Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12980","article-title":"Effect of vortioxetine vs. escitalopram on sexual functioning in adults with well-treated major depressive disorder experiencing SSRI-induced sexual dysfunction","volume":"12","author":"Jacobsen PL","year":"2015","unstructured":"Jacobsen PL, Mahableshwarkar AR, Chen Y, Chrones L, Clayton AH. Effect of vortioxetine vs. escitalopram on sexual functioning in adults with well-treated major depressive disorder experiencing SSRI-induced sexual dysfunction. J Sex Med. 2015, 12:2036-2048. 10.1111\/jsm.12980","journal-title":"J Sex Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109351966","article-title":"Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study","volume":"25","author":"Safarinejad MR","year":"2011","unstructured":"Safarinejad MR. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. J Psychopharmacol. 2011, 25:370-378. 10.1177\/0269881109351966","journal-title":"J Psychopharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v59n0304","article-title":"Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction","volume":"59","author":"Ashton AK","year":"1998","unstructured":"Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 1998, 59:112-115. 10.4088\/jcp.v59n0304","journal-title":"J Clin Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v65n0110","article-title":"A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction","volume":"65","author":"Clayton AH","year":"2004","unstructured":"Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004, 65:62-67. 10.4088\/jcp.v65n0110","journal-title":"J Clin Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v63n0302","article-title":"Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects","volume":"63","author":"Kennedy SH","year":"2002","unstructured":"Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. J Clin Psychiatry. 2002, 63:181-186. 10.4088\/jcp.v63n0302","journal-title":"J Clin Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1097-z","article-title":"Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury","volume":"161","author":"Dolberg OT","year":"2002","unstructured":"Dolberg OT, Klag E, Gross Y, Schreiber S. Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury. Psychopharmacology (Berl). 2002, 161:404-407. 10.1007\/s00213-002-1097-z","journal-title":"Psychopharmacology (Berl)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0593-0","article-title":"S-adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life","volume":"15","author":"Gao J","year":"2018","unstructured":"Gao J, Cahill CM, Huang X, et al.. S-adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life. Neurotherapeutics. 2018, 15:156-175. 10.1007\/s13311-017-0593-0","journal-title":"Neurotherapeutics"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16r11113","article-title":"S-adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research","volume":"78","author":"Sharma A","year":"2017","unstructured":"Sharma A, Gerbarg P, Bottiglieri T, et al.. S-adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research. J Clin Psychiatry. 2017, 78:e656-e667. 10.4088\/JCP.16r11113","journal-title":"J Clin Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2011.01.003","article-title":"SAMe and sexual functioning","volume":"27","author":"Dording CM","year":"2012","unstructured":"Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI. SAMe and sexual functioning. Eur Psychiatry. 2012, 27:451-454. 10.1016\/j.eurpsy.2011.01.003","journal-title":"Eur Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/0092623X.2021.1938764","article-title":"Effect of tribulus terrestris in the treatment of female sexual dysfunction and clitoral vascularization. Results of a randomized study comparing two different dosage regimes","volume":"47","author":"Vale FB","year":"2021","unstructured":"Vale FB, Boroni JD, Geber G, Antunes EM, Bretas T, Lopes GP, Geber S. Effect of tribulus terrestris in the treatment of female sexual dysfunction and clitoral vascularization. Results of a randomized study comparing two different dosage regimes. J Sex Marital Ther. 2021, 47:696-706. 10.1080\/0092623X.2021.1938764","journal-title":"J Sex Marital Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/2008-2231-22-40","article-title":"Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study","volume":"22","author":"Akhtari E","year":"2014","unstructured":"Akhtari E, Raisi F, Keshavarz M, et al.. Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study. Daru. 2014, 22:40. 10.1186\/2008-2231-22-40","journal-title":"Daru"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59091663","article-title":"Effects of aphrodite (an herbal compound) on SSRI-induced sexual dysfunctions and depression in females with major depressive disorder: findings from a randomized clinical trial","volume":"59","author":"Shahmoradi N","year":"2023","unstructured":"Shahmoradi N, Davarinejad O, Br\u00fchl AB, Brand S. Effects of aphrodite (an herbal compound) on SSRI-induced sexual dysfunctions and depression in females with major depressive disorder: findings from a randomized clinical trial. Medicina (Kaunas). 2023, 59:1663. 10.3390\/medicina59091663","journal-title":"Medicina (Kaunas)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1055\/a-0660-9565","article-title":"The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis","volume":"85","author":"T\u00f3th B","year":"2019","unstructured":"T\u00f3th B, Hegyi P, Lantos T, et al.. The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis. Planta Med. 2019, 85:24-31. 10.1055\/a-0660-9565","journal-title":"Planta Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2729-6","article-title":"Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial","volume":"223","author":"Modabbernia A","year":"2012","unstructured":"Modabbernia A, Sohrabi H, Nasehi AA, et al.. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 2012, 223:381-388. 10.1007\/s00213-012-2729-6","journal-title":"Psychopharmacology (Berl)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2282","article-title":"Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study","volume":"28","author":"Kashani L","year":"2013","unstructured":"Kashani L, Raisi F, Saroukhani S, et al.. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. Hum Psychopharmacol. 2013, 28:54-60. 10.1002\/hup.2282","journal-title":"Hum Psychopharmacol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1039\/c9fo02732g","article-title":"Medicinal effects of Peruvian maca (Lepidium meyenii): a review","volume":"11","author":"da Silva Leit\u00e3o Peres N","year":"2020","unstructured":"da Silva Leit\u00e3o Peres N, Cabrera Parra Bortoluzzi L, Medeiros Marques LL, Formigoni M, Fuchs RH, Droval AA, Reitz Cardoso FA. Medicinal effects of Peruvian maca (Lepidium meyenii): a review. Food Funct. 2020, 11:83-92. 10.1039\/c9fo02732g","journal-title":"Food Funct"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/949036","article-title":"A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women","volume":"2015","author":"Dording CM","year":"2015","unstructured":"Dording CM, Schettler PJ, Dalton ED, et al.. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. Evid Based Complement Alternat Med. 2015, 2015:949036. 10.1155\/2015\/949036","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/324369","article-title":"Effect of Lepidium meyenii Walp. on semen parameters and serum hormone levels in healthy adult men: a double-blind, randomized, placebo-controlled pilot study","volume":"2015","author":"Melnikovova I","year":"2015","unstructured":"Melnikovova I, Fait T, Kolarova M, Fernandez EC, Milella L. Effect of Lepidium meyenii Walp. on semen parameters and serum hormone levels in healthy adult men: a double-blind, randomized, placebo-controlled pilot study. Evid Based Complement Alternat Med. 2015, 2015:324369. 10.1155\/2015\/324369","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/hup.409","article-title":"A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction","volume":"17","author":"Kang BJ","year":"2002","unstructured":"Kang BJ, Lee SJ, Kim MD, Cho MJ. A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol. 2002, 17:279-284. 10.1002\/hup.409","journal-title":"Hum Psychopharmacol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1080\/00926239808404927","article-title":"Ginkgo biloba for antidepressant-induced sexual dysfunction","volume":"24","author":"Cohen AJ","year":"1998","unstructured":"Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther. 1998, 24:139-143. 10.1080\/00926239808404927","journal-title":"J Sex Marital Ther"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.5.836","article-title":"Antidepressant-induced sexual dysfunction and Ginkgo Biloba","volume":"157","author":"Ashton AK","year":"2000","unstructured":"Ashton AK, Ahrens K, Gupta S, Masand PS. Antidepressant-induced sexual dysfunction and Ginkgo Biloba. Am J Psychiatry. 2000, 157:836-837. 10.1176\/appi.ajp.157.5.836","journal-title":"Am J Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2020.04.388","article-title":"The effect of Ristela supplementation on female sexual function in women taking antidepressants: an open label trial","volume":"17","author":"Spadt SK","year":"2020","unstructured":"Spadt SK, Dweck A. The effect of Ristela supplementation on female sexual function in women taking antidepressants: an open label trial. J Sex Med. 2020, 17:259-260. 10.1016\/j.jsxm.2020.04.388","journal-title":"J Sex Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S78696","article-title":"Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial","volume":"11","author":"Farnia V","year":"2015","unstructured":"Farnia V, Shirzadifar M, Shakeri J, Rezaei M, Bajoghli H, Holsboer-Trachsler E, Brand S. Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial. Neuropsychiatr Dis Treat. 2015, 11:625-635. 10.2147\/NDT.S78696","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/394183-management-of-antidepressant-induced-sexual-dysfunction-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T17:16:39Z","timestamp":1755278199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/394183-management-of-antidepressant-induced-sexual-dysfunction-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.90170","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}